Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment

Randomized Multicenter Trial Assessing if Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Will Change Primary Treatment

The study is a prospective randomised multicenter trial assessing the additional value of breast MRI in women under 56 years of age with newly diagnosed breast cancer. Will preoperative breast MRI change treatment regimen? Will preoperative breast MRI reduce the number of primary surgeries? Will preoperative breast MRI increase the rate of mastectomies? Will preoperative breast MRI be cost effective?

Completed: the study has concluded normally; participants are no longer being examined or treated (i.e., last patient's last visit has occurred)

Inclusion Criteria:

• Women under 56 years of age
• Newly diagnosed breast cancer
• Swedish or English speaking

Exclusion Criteria:

• Claustrophobia
• Pregnancy
• Renal failure
• Metal items in patients